-
公开(公告)号:US12029764B2
公开(公告)日:2024-07-09
申请号:US16618148
申请日:2018-05-29
Applicant: STEMCELL TECHNOLOGIES CANADA INC.
Inventor: Charis-Patricia Segeritz , Ryan Conder , Michael Riedel
CPC classification number: A61K35/38 , A61L27/3633 , A61L27/3813 , A61L27/54 , A61L2300/434 , A61L2430/28 , G01N33/48
Abstract: A method for obtaining epithelial organoids is provided. In one embodiment, the method comprises culturing one or more epithelial ducts, epithelial duct fragments and/or epithelial stem cells isolated therefrom in contact with an extracellular matrix in the presence of a basal medium, wherein the medium is free of FGF and/or nicotinamide. Organoids obtained by the methods described herein, and uses thereof, are also provided.
-
12.
公开(公告)号:US12018240B2
公开(公告)日:2024-06-25
申请号:US17562815
申请日:2021-12-27
Applicant: STEMCELL TECHNOLOGIES CANADA INC.
Inventor: Maisam Dadgar , Jacquelyn L. Sikora Hanson , Armon R. Sharei
IPC: G01N33/68 , B01L3/00 , C07C309/65 , C07C309/73 , C12M1/26 , C12M3/06 , G01N21/33 , G01N21/64 , G01N33/52
CPC classification number: C12M23/16 , B01L3/502707 , C12M33/12 , B01L2200/12 , B01L2300/0819
Abstract: A microfluidic chip for causing the delivery of a payload to a cell comprises a plurality of constrictions configured to allow a cell suspension to flow through one or more of the plurality of constrictions from a first fluid flow region to a second fluid flow region within the microfluidic chip, wherein a cross-sectional width of each of the plurality of constrictions is less than a diameter of cells in the cell suspension, such that membranes of the cells are perturbed when passing through the constrictions such that a payload is able to pass through the perturbed cell membranes, and wherein a quotient of a cross-sectional area over a cross-sectional perimeter of each of the plurality of constrictions is greater than greater than or equal to 0.5 μm.
-
公开(公告)号:US20240191187A1
公开(公告)日:2024-06-13
申请号:US18555332
申请日:2022-04-14
Applicant: STEMCELL TECHNOLOGIES CANADA INC.
Inventor: David ROWBOTHAM , John STINGL
IPC: C12N5/071
CPC classification number: C12N5/0631 , C12N2501/11 , C12N2501/15 , C12N2501/155 , C12N2501/195 , C12N2501/415 , C12N2501/727 , C12N2513/00
Abstract: Disclosed are media, kits and methods for directed formation of mammary organoids. Embodiments of organoid media may be used to bias/enrich the formation of luminal organoids from isolated mammary epithelial cells. Embodiments of modified organoid media may be used to bias/enrich the formation of mixed lineage organoids from isolated mammary epithelial cells, or to subvert luminal organoids to mixed lineage organoids.
-
公开(公告)号:US20240002782A1
公开(公告)日:2024-01-04
申请号:US18038088
申请日:2021-11-25
Applicant: STEMCELL TECHNOLOGIES CANADA INC.
Inventor: Eric JERVIS , Kyle HUKEZALIE , Kylan WALSH , Tia SOJONKY , Karen MARKWICK , Michael HIATT
IPC: C12N5/00 , C12N5/074 , C12N5/0735
CPC classification number: C12N5/0018 , C12N5/0696 , C12N5/0606 , C12N2525/00
Abstract: Disclosed are liquids and methods for manipulating the localization and/or buoyancy of a population of particles, or one or more subpopulation thereof, within a volume of a liquid. The specific density of the liquids may be adjusted using specific gravity-modifying means depending on the application and/or on the average density of a population of particles, or one or more subpopulations thereof, within the liquid. For example, density-adjusted liquids may be used to bias a population of particles, or one or more subpopulations of particles, upward or downward within a volume of the liquid. As another example, density-adjusted liquids may be used to maintain the distribution of a population of neutrally buoyant particles, or one or more subpopulation thereof, within a volume of such liquid.
-
公开(公告)号:US20210230542A1
公开(公告)日:2021-07-29
申请号:US15734791
申请日:2019-06-06
Applicant: STEMCELL Technologies Canada Inc.
Inventor: Frann Antignano
Abstract: Kits, compositions and methods for enriching myeloid-derived suppressor cells (MDSCs) are provided. In one embodiment, the kit comprises (a) one or more antibodies or fragments thereof that bind one or more non-MDSC target cells; and (b) a plurality of particles, wherein the plurality of particles are linked or linkable to at least one of the one or more antibodies.
-
公开(公告)号:US20200017825A1
公开(公告)日:2020-01-16
申请号:US16480025
申请日:2018-01-23
Applicant: STEMCELL Technologies Canada Inc.
Inventor: ADAM HIRST , MELANIE KARDEL , WING CHANG , MICHAEL HIATT , ERIC JERVIS , ARWEN HUNTER
IPC: C12N5/0735 , C12N5/074
Abstract: The present disclosure relates to improved supplements, culture media and methods for enhancing the survival or proliferation of mammalian stem cells. In particular, adding a lipid supplement, such as a lipid-enriched carrier (e.g. a lipid-enriched albumin), to the culture medium may enhance the survival and/or proliferation of the stem cells by at least 5% to 65% as compared to a culture medium that does not contain the lipid supplement.
-
公开(公告)号:US20190040357A1
公开(公告)日:2019-02-07
申请号:US16108707
申请日:2018-08-22
Applicant: StemCell Technologies Canada Inc.
Inventor: Andy Isamu Kokaji
IPC: C12N5/078 , G01N33/569 , A23L2/52 , A61K31/07 , A61K31/122 , A61K31/197 , A61K31/198 , A61K31/221 , A61K31/355 , G01N33/543 , G01N1/40 , A61K33/30 , A61K33/06 , A61K33/04 , A61K33/00 , A61K31/714 , A61K31/593 , A61K31/525 , A61K31/519 , A61K31/51 , A61K31/455 , A61K31/4415 , A61K31/4188 , A61K31/385 , A61K31/375 , A23L33/155 , A23L33/12 , A23L33/175 , A23L33/105 , A23L33/16 , A23L33/15 , A23L33/10
Abstract: The present invention relates to methods for separating target cells from non-target cells using immunorosettes and magnetic particles. The method involves contacting a sample containing target cells and secondary targets such as erythrocytes with an antibody composition which allows immunorosettes of the target cells and the secondary targets to form. The sample is subsequently contacted with a second antibody composition which allows the binding of magnetic particles to the formed immunorosettes and free secondary targets. The immunorosettes and secondary targets labeled with magnetic particles are separated from non-target cells using a magnetic field. The antibody composition optionally contains bifunctional antibodies or tetrameric antibody complexes.
-
公开(公告)号:US20250163371A1
公开(公告)日:2025-05-22
申请号:US18841091
申请日:2023-02-22
Applicant: StemCell Technologies Canada Inc.
Inventor: Abdulkadir Ozkan , Chun-I Wu , Devin Bridgen , Jonathan Gilbert
IPC: C12N5/079
Abstract: The present disclosure provides methods for reprogramming a cell into a glial cell (e.g., an oligodendrocyte progenitor cell), wherein the method comprises passing a cell suspension comprising the cell and a glial cell reprogramming factor through a constriction, wherein the constriction deforms the cell, thereby causing a perturbation of the cell such that the glial cell reprogramming factor enters the cell.
-
19.
公开(公告)号:US20250043244A1
公开(公告)日:2025-02-06
申请号:US18709331
申请日:2022-11-14
Applicant: STEMCELL TECHNOLOGIES CANADA INC.
Inventor: Michael Finnan MALONEY , Emrah Ilker OZAY , Scott McNabb LOUGHHEAD , Rebecca Jean SILVER , Ashley BRATE , Murillo SILVA , Jonathan B. GILBERT , Devin BRIDGEN , Colin Joseph THALHOFER
IPC: C12N5/0783 , C07K14/54 , C07K14/55 , C07K14/705
Abstract: The present application provides TILs comprising agents that enhance activity and/or proliferative capacity of the TILs, methods of manufacturing such TILs. and methods of using such modified TILs for enhancing an immune response.
-
公开(公告)号:US20240426816A1
公开(公告)日:2024-12-26
申请号:US18750208
申请日:2024-06-21
Applicant: StemCell Technologies Canada Inc.
Inventor: Samuel Jon Clarke , Adil Kassam
IPC: G01N33/533 , G01N33/532 , G01N33/569 , G01N33/58
Abstract: This disclosure provides compositions and methods for a low-avidity, high-affinity and high-specificity biomolecular interaction that is rapidly reversible under physiological conditions. The methods comprise linking biological targets (such as molecules, proteins, DNA, cells, extracellular vesicles, etc.) with polymers and anti-polymer ligands and a way to reverse their binding using physiologically compatible polymeric compounds. The methods also comprise a way to combine different polymer/anti-polymer systems for orthogonal labeling. The compositions comprise labels including particles (fluorescent, magnetic, dense, etc.) conjugated to polymers or labels conjugated to anti-polymer antibodies. The compositions also comprise biomolecules (proteins, antibodies, DNA, etc.) conjugated to the polymers. These methods and compositions represent a major improvement to the state-of-the-art. They are particularly useful for separation and isolation of biological targets using particles, but have important application to other fields including fluorescent imaging.
-
-
-
-
-
-
-
-
-